
Sign up to save your podcasts
Or
Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depression
5
77 ratings
Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depression
1,040 Listeners
31 Listeners
274 Listeners
309 Listeners
331 Listeners
394 Listeners
122 Listeners
318 Listeners
198 Listeners
84 Listeners
88 Listeners
428 Listeners
147 Listeners
18 Listeners
84 Listeners